<p>阿爾法泰克控股公司（NASDAQ:ATEC - 獲取免費報告）主要股東 Squadron Capital Llc 於 11 月 12 日（星期三）出售了 250,000 股該公司的股票。股票以平均價格 20.80 美元出售，總價值為 5,200,000.00 美元。出售後，該內部人士在公司中持有 11,145,045 股，價值 231,816,936 美元。這筆交易代表其持股比例下降了 2.19%。該交易已在提交給證券交易委員會的文件中披露，相關文件可通過此鏈接獲取。持有公司 10% 或更多股份的主要股東需向 SEC 披露其買賣情況。</p>
<h2>阿爾法泰克股價表現</h2>
<p>阿爾法泰克股票在週五的交易時段下跌 0.46 美元，達到 19.74 美元。該公司交易了 2,603,589 股股票，而其平均交易量為 2,130,456 股。阿爾法泰克控股公司一年的最低股價為 8.18 美元，最高股價為 21.16 美元。該公司的市值為 29.3 億美元，市盈率為-17.47，貝塔值為 1.17。該公司的 50 日移動平均線為 15.99 美元，200 日移動平均線為 13.82 美元。該公司的速動比率為 1.77，流動比率為 2.88，債務與股本比率為 23.22。</p>
<p>阿爾法泰克（NASDAQ:ATEC - 獲取免費報告）最近於 10 月 30 日（星期四）發佈了季度財報。這家醫療技術公司報告本季度每股收益（EPS）為 0.03 美元，超出分析師一致預期的-0.06 美元，超出幅度為 0.09 美元。該公司本季度的收入為 1.965 億美元，而分析師預期為 1.8278 億美元。該公司的季度收入同比增長 30.4%。去年同期，該公司每股收益為-0.28 美元。阿爾法泰克已設定 2025 財年的每股收益指導。整體來看，研究分析師預測阿爾法泰克控股公司本財年的每股收益將為-1.08 美元。</p>
<h2>阿爾法泰克的機構交易</h2>
<p>一些機構投資者和對沖基金最近增加或減少了對 ATEC 的持股。德克薩斯州教師退休系統在第一季度新購入了阿爾法泰克的股份，價值 158,000 美元。Envestnet 資產管理公司在第一季度將其在阿爾法泰克的持股增加了 1.2%。Envestnet 資產管理公司目前持有 390,414 股該醫療技術公司的股票，價值 3,959,000 美元，此前在上個季度又購買了 4,754 股。紐約州共同退休基金在第一季度將其在阿爾法泰克的持股增加了 1.8%。紐約州共同退休基金目前持有 1,224,005 股該醫療技術公司的股票，價值 12,411,000 美元，此前在上個季度又購買了 21,671 股。CWM LLC 在第一季度將其在阿爾法泰克的持股增加了 67.2%。CWM LLC 目前持有 31,336 股該醫療技術公司的股票，價值 318,000 美元，此前在上個季度又購買了 12,598 股。最後，Larson Financial Group LLC 在第一季度新購入了阿爾法泰克的股份，價值約 54,000 美元。機構投資者持有該公司 66.35% 的股票。</p>
<h2>分析師評級調整</h2>
<p>幾位股票研究分析師對 ATEC 股票發表了評論。富國銀行將阿爾法泰克的目標價從 14.00 美元上調至 16.00 美元，並在 10 月 16 日的研究報告中給予該股票 “超配” 評級。摩根士丹利將阿爾法泰克的目標價從 16.00 美元上調至 21.00 美元，並在週一的報告中給予該公司 “持平” 評級。Canaccord Genuity Group 將阿爾法泰克的目標價從 20.00 美元上調至 25.00 美元，並在 10 月 31 日的研究報告中給予該公司 “買入” 評級。巴克萊將阿爾法泰克的目標價從 22.00 美元上調至 23.00 美元，並在 11 月 3 日的研究報告中給予該公司 “超配” 評級。最後，Lake Street Capital 將阿爾法泰克的目標價設定為 25.00 美元，並在 10 月 31 日的研究報告中給予該股票 “買入” 評級。九位投資分析師對該股票給予 “買入” 評級，一位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “適度買入”，共識目標價為 22.00 美元。</p>
<p><strong>閲讀我們關於阿爾法泰克的最新報告</strong></p>
<h2>阿爾法泰克公司簡介</h2>
<p>（獲取免費報告）</p>
<p>阿爾法泰克控股公司是一家醫療技術公司，設計、開發並推進用於美國及國際上脊柱疾病外科治療的技術。它通過第三方供應商製造和銷售植入物和器械。該公司提供 Alpha InformatiX 產品平台，包括提供全身成像的 EOS 成像系統；利用 EOS 技術更快速量化對齊參數的 VEA 對齊移動應用；自動化肌電圖和體感誘發電位監測的 SafeOp Neural InformatiX 系統；以及將導航和機器人集成到脊柱手術中的 Valence 術中系統，以及 Sigma Prone TransPsoas (PTP) 進入和 PTP 患者定位系統。</p>
<h2>另見</h2>
<ul>
<li>我們更看好的五隻股票，勝過阿爾法泰克</li>
<li>什麼是 WallStreetBets，他們針對哪些股票？</li>
<li>如果你等着抄底，美光科技可能會讓你錯過機會</li>
<li>為什麼投資 5G？如何投資 5G 股票</li>
<li>三隻悄然推動 AI 和科技革命的股票</li>
<li>異常交易量的股票：如何實時發現異常交易量的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVRFQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVRFQw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在阿爾法泰克嗎？</h2>
<p>在你考慮阿爾法泰克之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛市場注意到之前購買的股票……而阿爾法泰克並不在名單上。</p>
<p>雖然阿爾法泰克目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

阿爾法泰克控股

<p>Squadron Capital LLC，阿爾法泰克控股（NASDAQ:ATEC）的主要股東，出售了 250,000 股，價格為每股 20.80 美元，總計 520 萬美元。這次出售使他們的持股比例減少了 2.19%，剩餘持有 11,145,045 股。該交易已向美國證券交易委員會（SEC）披露。阿爾法泰克的股票交易價格為 19.74 美元，市值為 29.3 億美元。分析師對該股票持積極展望，多位分析師上調了其目標價格</p>

<p>Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) major shareholder Squadron Capital Llc sold 250,000 shares of the firm's stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $20.80, for a total value of $5,200,000.00. Following the sale, the insider owned 11,145,045 shares in the company, valued at $231,816,936. This trade represents a 2.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available at this link. Major shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.</p>
<div class="lb-trans"><p>阿爾法泰克控股公司（NASDAQ:ATEC - 獲取免費報告）主要股東 Squadron Capital Llc 於 11 月 12 日（星期三）出售了 250,000 股該公司的股票。股票以平均價格 20.80 美元出售，總價值為 5,200,000.00 美元。出售後，該內部人士在公司中持有 11,145,045 股，價值 231,816,936 美元。這筆交易代表其持股比例下降了 2.19%。該交易已在提交給證券交易委員會的文件中披露，相關文件可通過此鏈接獲取。持有公司 10% 或更多股份的主要股東需向 SEC 披露其買賣情況。</p>
</div><h2>Alphatec Price Performance</h2>
<div class="lb-trans"><h2>阿爾法泰克股價表現</h2>
</div><p>Shares of Alphatec stock traded down $0.46 during trading hours on Friday, reaching $19.74. 2,603,589 shares of the company's stock were exchanged, compared to its average volume of 2,130,456. Alphatec Holdings, Inc. has a 1 year low of $8.18 and a 1 year high of $21.16. The company has a market capitalization of $2.93 billion, a P/E ratio of -17.47 and a beta of 1.17. The business has a fifty day moving average of $15.99 and a two-hundred day moving average of $13.82. The company has a quick ratio of 1.77, a current ratio of 2.88 and a debt-to-equity ratio of 23.22.</p>
<div class="lb-trans"><p>阿爾法泰克股票在週五的交易時段下跌 0.46 美元，達到 19.74 美元。該公司交易了 2,603,589 股股票，而其平均交易量為 2,130,456 股。阿爾法泰克控股公司一年的最低股價為 8.18 美元，最高股價為 21.16 美元。該公司的市值為 29.3 億美元，市盈率為-17.47，貝塔值為 1.17。該公司的 50 日移動平均線為 15.99 美元，200 日移動平均線為 13.82 美元。該公司的速動比率為 1.77，流動比率為 2.88，債務與股本比率為 23.22。</p>
</div><p>Alphatec (NASDAQ:ATEC - Get Free Report) last issued its quarterly earnings results on Thursday, October 30th. The medical technology company reported $0.03 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.09. The business had revenue of $196.50 million for the quarter, compared to analysts' expectations of $182.78 million. The firm's revenue for the quarter was up 30.4% on a year-over-year basis. During the same quarter last year, the company earned ($0.28) earnings per share. Alphatec has set its FY 2025 guidance at EPS. As a group, research analysts predict that Alphatec Holdings, Inc. will post -1.08 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>阿爾法泰克（NASDAQ:ATEC - 獲取免費報告）最近於 10 月 30 日（星期四）發佈了季度財報。這家醫療技術公司報告本季度每股收益（EPS）為 0.03 美元，超出分析師一致預期的-0.06 美元，超出幅度為 0.09 美元。該公司本季度的收入為 1.965 億美元，而分析師預期為 1.8278 億美元。該公司的季度收入同比增長 30.4%。去年同期，該公司每股收益為-0.28 美元。阿爾法泰克已設定 2025 財年的每股收益指導。整體來看，研究分析師預測阿爾法泰克控股公司本財年的每股收益將為-1.08 美元。</p>
</div><h2>Institutional Trading of Alphatec</h2>
<div class="lb-trans"><h2>阿爾法泰克的機構交易</h2>
</div><p>A number of institutional investors and hedge funds have recently added to or reduced their stakes in ATEC. Teacher Retirement System of Texas acquired a new position in Alphatec during the first quarter worth $158,000. Envestnet Asset Management Inc. increased its position in shares of Alphatec by 1.2% during the 1st quarter. Envestnet Asset Management Inc. now owns 390,414 shares of the medical technology company's stock worth $3,959,000 after purchasing an additional 4,754 shares in the last quarter. New York State Common Retirement Fund lifted its holdings in Alphatec by 1.8% during the 1st quarter. New York State Common Retirement Fund now owns 1,224,005 shares of the medical technology company's stock valued at $12,411,000 after purchasing an additional 21,671 shares during the last quarter. CWM LLC boosted its position in Alphatec by 67.2% in the first quarter. CWM LLC now owns 31,336 shares of the medical technology company's stock valued at $318,000 after buying an additional 12,598 shares in the last quarter. Finally, Larson Financial Group LLC bought a new stake in Alphatec during the first quarter worth about $54,000. Institutional investors own 66.35% of the company's stock.</p>
<div class="lb-trans"><p>一些機構投資者和對沖基金最近增加或減少了對 ATEC 的持股。德克薩斯州教師退休系統在第一季度新購入了阿爾法泰克的股份，價值 158,000 美元。Envestnet 資產管理公司在第一季度將其在阿爾法泰克的持股增加了 1.2%。Envestnet 資產管理公司目前持有 390,414 股該醫療技術公司的股票，價值 3,959,000 美元，此前在上個季度又購買了 4,754 股。紐約州共同退休基金在第一季度將其在阿爾法泰克的持股增加了 1.8%。紐約州共同退休基金目前持有 1,224,005 股該醫療技術公司的股票，價值 12,411,000 美元，此前在上個季度又購買了 21,671 股。CWM LLC 在第一季度將其在阿爾法泰克的持股增加了 67.2%。CWM LLC 目前持有 31,336 股該醫療技術公司的股票，價值 318,000 美元，此前在上個季度又購買了 12,598 股。最後，Larson Financial Group LLC 在第一季度新購入了阿爾法泰克的股份，價值約 54,000 美元。機構投資者持有該公司 66.35% 的股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級調整</h2>
</div><p>Several equities research analysts have commented on ATEC shares. Wells Fargo &amp; Company upped their price target on Alphatec from $14.00 to $16.00 and gave the stock an &#34;overweight&#34; rating in a research note on Thursday, October 16th. Morgan Stanley upped their price target on Alphatec from $16.00 to $21.00 and gave the company an &#34;equal weight&#34; rating in a report on Monday. Canaccord Genuity Group lifted their price objective on Alphatec from $20.00 to $25.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, October 31st. Barclays raised their price objective on shares of Alphatec from $22.00 to $23.00 and gave the company an &#34;overweight&#34; rating in a research report on Monday, November 3rd. Finally, Lake Street Capital set a $25.00 target price on shares of Alphatec and gave the stock a &#34;buy&#34; rating in a research report on Friday, October 31st. Nine investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $22.00.</p>
<div class="lb-trans"><p>幾位股票研究分析師對 ATEC 股票發表了評論。富國銀行將阿爾法泰克的目標價從 14.00 美元上調至 16.00 美元，並在 10 月 16 日的研究報告中給予該股票 “超配” 評級。摩根士丹利將阿爾法泰克的目標價從 16.00 美元上調至 21.00 美元，並在週一的報告中給予該公司 “持平” 評級。Canaccord Genuity Group 將阿爾法泰克的目標價從 20.00 美元上調至 25.00 美元，並在 10 月 31 日的研究報告中給予該公司 “買入” 評級。巴克萊將阿爾法泰克的目標價從 22.00 美元上調至 23.00 美元，並在 11 月 3 日的研究報告中給予該公司 “超配” 評級。最後，Lake Street Capital 將阿爾法泰克的目標價設定為 25.00 美元，並在 10 月 31 日的研究報告中給予該股票 “買入” 評級。九位投資分析師對該股票給予 “買入” 評級，一位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 “適度買入”，共識目標價為 22.00 美元。</p>
</div><p><strong>Read Our Latest Report on Alphatec</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於阿爾法泰克的最新報告</strong></p>
</div><h2>Alphatec Company Profile</h2>
<div class="lb-trans"><h2>阿爾法泰克公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.</p>
<div class="lb-trans"><p>阿爾法泰克控股公司是一家醫療技術公司，設計、開發並推進用於美國及國際上脊柱疾病外科治療的技術。它通過第三方供應商製造和銷售植入物和器械。該公司提供 Alpha InformatiX 產品平台，包括提供全身成像的 EOS 成像系統；利用 EOS 技術更快速量化對齊參數的 VEA 對齊移動應用；自動化肌電圖和體感誘發電位監測的 SafeOp Neural InformatiX 系統；以及將導航和機器人集成到脊柱手術中的 Valence 術中系統，以及 Sigma Prone TransPsoas (PTP) 進入和 PTP 患者定位系統。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Alphatec</li>
<li>What Is WallStreetBets and What Stocks Are They Targeting?</li>
<li>If You Wait for the Dip, Micron Technology Could Leave You Behind</li>
<li>Why Invest in 5G? How to Invest in 5G Stocks</li>
<li>3 Stocks Quietly Powering the AI and Tech Revolution</li>
<li>Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time</li>
<li>Jefferies Tells NVIDIA to Step Aside, Picks Broadcom as Top Semiconductor Stock</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過阿爾法泰克</li>
<li>什麼是 WallStreetBets，他們針對哪些股票？</li>
<li>如果你等着抄底，美光科技可能會讓你錯過機會</li>
<li>為什麼投資 5G？如何投資 5G 股票</li>
<li>三隻悄然推動 AI 和科技革命的股票</li>
<li>異常交易量的股票：如何實時發現異常交易量的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVRFQw" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NASDAQ&amp;Symbol=ATEC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Alphatec Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在阿爾法泰克嗎？</h2>
</div><p>Before you consider Alphatec, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮阿爾法泰克之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alphatec wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛市場注意到之前購買的股票……而阿爾法泰克並不在名單上。</p>
</div><p>While Alphatec currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然阿爾法泰克目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

阿爾法泰克控股 (NASDAQ:ATEC) 的主要股東 Squadron Capital Llc 出售了 250,000 股